COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention

Research output: Contribution to journalReview article (Academic Journal)peer-review

31 Downloads (Pure)

Abstract

While the COVID-19 pandemic continues to spread rapidly, resulting in considerable morbidity and mortality worldwide, multiple efforts are being made by the international scientific community to understand the pathogenesis of the viral infection and its clinical outcome. Older age and comorbidities have consistently been reported as risk factors for unfavorable prognosis, with cardiovascular disease accounting for up to 10 % of comorbid conditions among the infected patients. An understanding of the mechanism underlying the effect of this infection on patients with cardiovascular disease is essential to manage and improve clinical strategies against the disease in that population. In this review, we summarize the impact of COVID-19 on patients with underlying cardiovascular conditions and the cardiac implications of known and emerging therapeutic strategies. Our future effort will aim to further elucidate how the type and severity of the cardiac disease, with particular regard to Congenital Heart Disease, influences the prognosis and the outcome of the viral infection.
Original languageEnglish
Number of pages9
JournalFrontiers in Cardiovascular Medicine
DOIs
Publication statusPublished - 14 Jul 2020

Structured keywords

  • Covid19
  • Bristol Heart Institute

Keywords

  • COVID-19
  • cardiovascular disease
  • congenital heart defect
  • pediatric
  • cell therapy

Fingerprint

Dive into the research topics of 'COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention'. Together they form a unique fingerprint.

Cite this